Mel Spigelman, M.D.
President and Chief Executive Officer
Media Support
TB Alliance Information
Background
Leadership Biographies
Joanna Breitstein
Director, Communications
Elizabeth Gardiner, M.Sc.
Vice President, Market Access
Stephen Jasko, M.B.A.
Chief Financial Officer
Robert C. Lorette, Esq.
Senior Vice President, Business Development
Carl Mendel, M.D.
Senior Vice President, Research and Development
Colleen Pero, M.A.
Chief Administrative Officer
Fact Sheets
News and Coverage
Recent Coverage
Tuberculosis success
3/1/2013 | Dan Jones | Nature Drug DiscoveryLos Angeles health officials concerned about TB outbreak on skid row
2/22/2013 | Reuters | The ScientistFirst novel anti-tuberculosis drug in 40 years
2/7/2013 | Randy Osborne | Nature BiotechnologyNeglected diseases see few new drugs despite upped investment
1/7/2013 | Cassandra Willyard | Nature MedicineJ&J Tuberculosis Drug Gets Fast-Track Clearance
1/2/2013 | Joseph Walker and Nathalie Tadena | Wall Street JournalJohnson & Johnson set to ship TB medicine
1/2/2013 | Andrew Jack | Financial TimesUS Approves Drug-Resistant Tuberculosis Treatment Print
1/1/2013 | Voice of AmericaRecent TB Alliance News Releases
UNITAID and TB Alliance Call For More Action Against Childhood Tuberculosis
In TB Fight, Children Must Be a PriorityIn spite of an estimated 500,000 new annual cases of children with tuberculosis (TB), there are no appropriate medicines for them, UNITAID and the TB ...
PSI CEO Karl Hofmann Elected President of TB Alliance’s Stakeholders Association, Joins Board of Directors
Global health expert and diplomat to lend skills, support to optimize new TB drug introductionsTB Alliance, a not-for-profit organization with the mission of developing new, improved, and affordable TB treatments, announces the election of Karl ...
TB Alliance Announces TB Veteran Dr. Carlos Morel as Chairman of its Board of Directors
Board leadership brings unparalleled experience in the fieldThe Global Alliance for TB Drug Development (TB Alliance) is pleased to announce the appointment of Dr. Carlos Morel to Chairman of its Board of Direc...
TB Alliance Publications
Falling Short: Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis
New TB Regimens: What Countries Want
The Value Proposition of Existing and New First-Line Regimens for Drug-Susceptible Tuberculosis
Pathway to Patients
Charting the Dynamics of the Global TB Drug Market
Policy on the Compassionate / Emergency Use of Experimental TB Alliance Drugs
Site by Darby Communications
© 2013 Global Alliance for TB Drug Development